The groundbreaking treatment of the medication represents a major development in the management of type 2 diabetes. Different to existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 https://tirzepatidepeptide000920.worldblogged.com/48413075/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment